Company Filing History:
Years Active: 1981-1985
Title: The Innovations of Stanley W. Morgenstern
Introduction
Stanley W. Morgenstern is a notable inventor based in Neptune, NJ (US). He has made significant contributions to the field of biochemistry, particularly through his innovative patents. With a total of 2 patents to his name, Morgenstern's work has had a meaningful impact on the measurement of alpha-amylase in body fluids.
Latest Patents
Morgenstern's latest patents include the "Alpha-amylase assay and substrates for use therein." This invention involves a maltodextrin phosphorylase limit dextrin in the presence of maltodextrin phosphorylase and inorganic phosphate. It serves as a substrate for alpha-amylase, initiating a series of enzymatic reactions that result in a chromogen response. This response can be utilized to measure the concentration of alpha-amylase in body fluids. Additionally, a novel limit dextrin and its preparation are described in the patent.
Career Highlights
Throughout his career, Stanley W. Morgenstern has worked with prominent companies such as Cooper Biomedical, Inc. and Worthington Biochemical Corporation. His experience in these organizations has contributed to his expertise in the field of biochemistry and innovation.
Collaborations
Morgenstern has collaborated with notable coworkers, including Paul T. Nix and Rebecca D. Goldfarb. These partnerships have likely enriched his work and led to further advancements in his inventions.
Conclusion
Stanley W. Morgenstern's contributions to the field of biochemistry through his patents and collaborations highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence the measurement of important biochemical markers in medical diagnostics.